Left Atrial and Left Atrial Appendage 4D Blood Flow Dynamics in Atrial Fibrillation
暂无分享,去创建一个
Michael Markl | Daniel C. Lee | Jason Ng | Jeffrey J. Goldberger | M. Markl | J. Goldberger | J. Ng | J. Carr | Maria Carr | Nicholas Furiasse | M. Carr | James Carr | Nicholas Furiasse | Charles Foucar | C. Foucar
[1] M. Ezekowitz,et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.
[2] Conti Cr. ATRIAL FIBRILLATION, TRANSESOPHAGEAL ECHO, ELECTRICAL CARDIOVERSION, AND ANTICOAGULATION , 1994 .
[3] M. Aguilar,et al. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.
[4] S. Yusuf,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.
[5] A. Camm,et al. Left atrial appendage: structure, function, and role in thromboembolism , 1999, Heart.
[6] Velocity Quantification by Electrocardiography-Gated Phase Contrast Magnetic Resonance Imaging in Patients With Cardiac Arrhythmia: A Simulation Study Based on Real Time Transesophageal Echocardiography Data in Atrial Fibrillation , 2015, Journal of computer assisted tomography.
[7] P. Walker,et al. Semiautomated method for noise reduction and background phase error correction in MR phase velocity data , 1993, Journal of magnetic resonance imaging : JMRI.
[8] Daniel C. Lee,et al. Three-dimensional left atrial blood flow characteristics in patients with atrial fibrillation assessed by 4D flow CMR. , 2016, European heart journal cardiovascular Imaging.
[9] Michael Markl,et al. Left atrial flow velocity distribution and flow coherence using four‐dimensional FLOW MRI: A pilot study investigating the impact of age and Pre‐ and Postintervention atrial fibrillation on atrial hemodynamics , 2013, Journal of magnetic resonance imaging : JMRI.
[10] D. Lane,et al. A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice , 2011, Journal of thrombosis and haemostasis : JTH.
[11] Michael Markl,et al. 4D flow MRI , 2012, Journal of magnetic resonance imaging : JMRI.
[12] M. Ezekowitz,et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. , 2014, Circulation.
[13] Michael Markl,et al. Left Atrial 4-Dimensional Flow Magnetic Resonance Imaging: Stasis and Velocity Mapping in Patients With Atrial Fibrillation , 2016, Investigative radiology.
[14] D. Singer,et al. Thirty-Day Mortality After Ischemic Stroke and Intracranial Hemorrhage in Patients With Atrial Fibrillation On and Off Anticoagulants , 2012, Stroke.
[15] Mann Wj. Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation. , 1995 .
[16] Sanghamitra Mohanty,et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. , 2012, Journal of the American College of Cardiology.
[17] J. Halperin,et al. Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The Stroke Prevention in Atrial Fibrillation [SPAF-III] study). , 1999, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] Michael Markl,et al. Age, gender, blood pressure, and ventricular geometry influence normal 3D blood flow characteristics in the left heart. , 2013, European heart journal cardiovascular Imaging.
[19] M. Olschewski,et al. Left atrial appendage flow velocity as a quantitative surrogate parameter for thromboembolic risk: determinants and relationship to spontaneous echocontrast and thrombus formation--a transesophageal echocardiographic study in 500 patients with cerebral ischemia. , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[20] Charles J Bruce,et al. Guidelines for Performing a Comprehensive Transesophageal Echocardiographic Examination: Recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists , 2007, Anesthesia and Analgesia.
[21] Silvia G Priori,et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. , 2011, Circulation.
[22] Michael Markl,et al. Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate , 2015, Circulation.
[23] T Ebbers,et al. Three dimensional flow in the human left atrium , 2001, Heart.
[24] T Ebbers,et al. Noninvasive measurement of time-varying three-dimensional relative pressure fields within the human heart. , 2002, Journal of biomechanical engineering.
[25] M. Yacoub,et al. Asymmetric redirection of flow through the heart , 2000, Nature.
[26] M. Alley,et al. Characteristics of intra-left atrial flow dynamics and factors affecting formation of the vortex flow – analysis with phase-resolved 3-dimensional cine phase contrast magnetic resonance imaging. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[27] Gregory Y H Lip,et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.
[28] N J Pelc,et al. Concomitant gradient terms in phase contrast MR: Analysis and correction , 1998, Magnetic resonance in medicine.
[29] Jennifer G. Robinson,et al. ACCF/AHA TASK FORCE MEMBERS , 2013 .
[30] M. Aguilar,et al. Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Stroke in Patients With Nonvalvular Atrial Fibrillation and No History of Stroke or Transient Ischemic Attacks , 2008 .
[31] C. Murray,et al. Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.
[32] Jeroen J. Bax,et al. Flow Assessment Through Four Heart Valves Simultaneously Using 3-Dimensional 3-Directional Velocity-Encoded Magnetic Resonance Imaging With Retrospective Valve Tracking in Healthy Volunteers and Patients With Valvular Regurgitation , 2009, Investigative radiology.
[33] C. Pollick,et al. Assessment of Left Atrial Appendage Function by Transesophageal Echocardiography: Implications for the Development of Thrombus , 1991, Circulation.
[34] Yuchiao Chang,et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.
[35] Leon Poller,et al. Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.